Determination of ultra-trace metal-protein interactions in co-formulated monoclonal antibody drug product by SEC-ICP-MS

Transition metals can be introduced in therapeutic protein drugs at various steps of the manufacturing process (e.g. manufacturing raw materials, formulation, storage), and can cause a variety of modifications on the protein. These modifications can potentially influence the efficacy, safety, and st...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitty-Léveillé, Laurence, VanAernum, Zachary L., Pavon, Jorge Alexander, Murphy, Christa, Neal, Katie, Forest, William, Gao, Xinliu, Zhong, Wendy, Richardson, Douglas D., Schuessler, Hillary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085571/
https://www.ncbi.nlm.nih.gov/pubmed/37032437
http://dx.doi.org/10.1080/19420862.2023.2199466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085571/
https://www.ncbi.nlm.nih.gov/pubmed/37032437
http://dx.doi.org/10.1080/19420862.2023.2199466

Ejemplares similares